Healthy subjects
Conditions
Interventions
None listed
Sponsors
Macromill, Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1)Women between 20 and 45 years of age at the time of obtaining consent to participate in the study (2)Subjects with subjective symptoms of PMS (3)Menstrual cycle of 25 to 38 days (4)Those whose most recent menstrual period was between 13 and 20 days at the time of the first survey distribution. (5)Those who have been fully informed of the purpose and content of this study, have the capacity to consent, and who volunteer of their own free will with full understanding, and whose consent can be obtained through electromagnetic informed consent.
Exclusion criteria
Exclusion criteria: (1)Menopausal women (2)Currently using medications that affect ovulation (oral contraceptives (birth control pills), ovulation suppressants, hormonal agents) (3)Who are currently receiving treatment or medication by a physician for a gynecological disorder (menopause, hormone replacement therapy, uterine, ovarian, or mammary gland disease, etc.) (4)Who are currently receiving treatment or medication by a physician for a mental disorder (depression, anxiety, insomnia, panic disorder, etc.) (5)Women who are currently pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of anterior and posterior scale questionnaires | — |
Secondary
| Measure | Time frame |
|---|---|
| (1)PMTS-VAS (2)PMTS-SR (3)DRSP (4)Modified MDQ (5)POMS-2 shortened version for adults (6)Comparison of Likert Scale and Visual Analog Scale (VAS) | — |
Countries
Japan
Contacts
Public ContactYuki Mori
Macromill, Inc. Life Science Division
Outcome results
None listed